Kaushik Kumar Dey
Kaushik Kumar Dey
Postdoctoral Research Associate
Verified email at stjude.org
Title
Cited by
Cited by
Year
Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma
S Das, KK Dey, G Dey, I Pal, A Majumder, S MaitiChoudhury, M Mandal
PLoS One 7 (10), e46641, 2012
1242012
Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells
S Rajput, BNP Kumar, KK Dey, I Pal, A Parekh, M Mandal
Life sciences 93 (21), 783-790, 2013
1052013
Deep multilayer brain proteomics identifies molecular networks in Alzheimer’s disease progression
B Bai, X Wang, Y Li, PC Chen, K Yu, KK Dey, JM Yarbro, X Han, BM Lutz, ...
Neuron 105 (6), 975-991. e7, 2020
922020
Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer
G Dey, R Bharti, G Dhanarajan, S Das, KK Dey, BNP Kumar, R Sen, ...
Scientific reports 5 (1), 1-14, 2015
792015
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling
BNP Kumar, S Rajput, KK Dey, A Parekh, S Das, A Mazumdar, M Mandal
Bmc Cancer 13 (1), 1-15, 2013
642013
Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease
KK Dey, H Wang, M Niu, B Bai, X Wang, Y Li, JH Cho, H Tan, A Mishra, ...
Clinical proteomics 16 (1), 1-12, 2019
492019
Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy
R Bharti, G Dey, I Banerjee, KK Dey, S Parida, BNP Kumar, CK Das, I Pal, ...
Cancer letters 388, 292-302, 2017
472017
Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy
S Parida, C Maiti, Y Rajesh, KK Dey, I Pal, A Parekh, R Patra, D Dhara, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (1), 3039-3052, 2017
452017
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo
A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ...
Oncogene 37 (33), 4546-4561, 2018
422018
Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis
I Pal, Y Rajesh, P Banik, G Dey, KK Dey, R Bharti, D Naskar, ...
Cancer letters 452, 254-263, 2019
212019
Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease
H Wang, KK Dey, PC Chen, Y Li, M Niu, JH Cho, X Wang, B Bai, Y Jiao, ...
Molecular neurodegeneration 15 (1), 1-20, 2020
202020
S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway
KK Dey, R Bharti, G Dey, I Pal, Y Rajesh, S Chavan, S Das, CK Das, ...
Cancer gene therapy 23 (11), 382-391, 2016
202016
Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management
Y Rajesh, A Banerjee, I Pal, A Biswas, S Das, KK Dey, N Kapoor, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1863 (7), 1196-1209, 2019
182019
Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma
I Pal, KK Dey, M Chaurasia, S Parida, S Das, Y Rajesh, K Sharma, ...
Tumor Biology 37 (5), 6389-6402, 2016
172016
Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach
KK Dey, I Pal, R Bharti, G Dey, BNP Kumar, S Rajput, A Parekh, S Parida, ...
Tumor Biology 36 (12), 9829-9837, 2015
172015
Isotope Labeling-Assisted Evaluation of Hydrophilic and Hydrophobic Liquid Chromatograph–Mass Spectrometry for Metabolomics Profiling
B Xie, Y Wang, DR Jones, KK Dey, X Wang, Y Li, JH Cho, TI Shaw, H Tan, ...
Analytical chemistry 90 (14), 8538-8545, 2018
132018
Blockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinoma
I Pal, S Parida, BNP Kumar, P Banik, KK Dey, S Chakraborty, SK Bhutia, ...
European journal of pharmacology 765, 217-227, 2015
122015
BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt
I Pal, S Sarkar, S Rajput, KK Dey, S Chakraborty, R Dash, SK Das, ...
British journal of cancer 111 (1), 101-111, 2014
122014
PKI 166 induced redox signalling and apoptosis through activation of p53, MAP Kinase and caspase pathway in epidermoid carcinoma.
S Das, KK Dey, R Bharti, S MaitiChoudhury, S Maiti, M Mandal
Journal of experimental therapeutics & oncology 10 (2), 2012
102012
Deep profiling of microgram-scale proteome by tandem mass tag mass spectrometry
D Liu, S Yang, K Kavdia, JM Sifford, Z Wu, B Xie, Z Wang, VR Pagala, ...
Journal of Proteome Research 20 (1), 337-345, 2020
32020
The system can't perform the operation now. Try again later.
Articles 1–20